New eye drug aims to improve vision in diabetes patients
Disease control
Ongoing
This study tests a new medicine called EYE103 for people with diabetic macular edema, a condition that causes vision loss due to diabetes. About 1054 adults will receive either EYE103 or the standard treatment ranibizumab as eye injections every 4 weeks for the first year, then l…
Phase: PHASE2, PHASE3 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC